ARISAPH Trademark

Trademark Overview

On Monday, May 12, 2014, a trademark application was filed for ARISAPH with the United States Patent and Trademark Office. The USPTO has given the ARISAPH trademark a serial number of 86278628. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 8, 2018. This trademark is owned by Arisaph Pharmaceuticals, Inc.. The ARISAPH trademark is filed in the Pharmaceutical Products category with the following description:

Pharmacological preparations and substances for the treatment of diabetes, cancer, and atherosclerosis
arisaph

General Information

Serial Number86278628
Word MarkARISAPH
Filing DateMonday, May 12, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 8, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2014

Trademark Statements

Goods and ServicesPharmacological preparations and substances for the treatment of diabetes, cancer, and atherosclerosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 23, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameArisaph Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02110
Party NameArisaph Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02110

Trademark Events

Event DateEvent Description
Monday, January 8, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 8, 2018ABANDONMENT - NO USE STATEMENT FILED
Saturday, May 6, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 5, 2017EXTENSION 5 GRANTED
Monday, May 1, 2017EXTENSION 5 FILED
Monday, May 1, 2017TEAS EXTENSION RECEIVED
Thursday, December 15, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, December 14, 2016EXTENSION 4 GRANTED
Friday, November 18, 2016EXTENSION 4 FILED
Wednesday, December 14, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, November 18, 2016TEAS EXTENSION RECEIVED
Tuesday, May 3, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, April 30, 2016EXTENSION 3 GRANTED
Monday, April 25, 2016EXTENSION 3 FILED
Monday, April 25, 2016TEAS EXTENSION RECEIVED
Thursday, October 15, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 14, 2015EXTENSION 2 GRANTED
Monday, October 5, 2015EXTENSION 2 FILED
Thursday, October 8, 2015CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 5, 2015TEAS EXTENSION RECEIVED
Tuesday, May 26, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, May 22, 2015EXTENSION 1 GRANTED
Friday, May 22, 2015EXTENSION 1 FILED
Friday, May 22, 2015TEAS EXTENSION RECEIVED
Tuesday, December 2, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 7, 2014OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, October 7, 2014PUBLISHED FOR OPPOSITION
Wednesday, September 17, 2014NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, August 27, 2014APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 26, 2014ASSIGNED TO EXAMINER
Friday, May 23, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, May 16, 2014APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, May 16, 2014TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, May 19, 2014TEAS VOLUNTARY AMENDMENT RECEIVED
Thursday, May 15, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

arisaph cancer atherosclerosis diabetes treatment preparations substances pharmacological